Vivesto Stock

Vivesto P/CF

The P/CF (Price-to-Cash-Flow Ratio) of Vivesto (VIVE.ST) as of Aug 11, 2026 is -1.32. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was -1.12 — a change of 17.13% (lower).

P/CF

-1.32

YoY

17.13%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of Vivesto is 2026 -1.32 . P/CF (Price-to-Cash-Flow Ratio) of Vivesto was 2025 -1.12 . It decreases by 17.13% lower compared to the previous year.
Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vivesto stock

P/CF (Price-to-Cash-Flow Ratio) of Vivesto is -1.32 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of Vivesto changed from -1.12 to -1.32, representing a 17.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) Vivesto since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s Vivesto with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Vivesto

All Key Metrics — Vivesto